Brain glutamine and glutamate levels in patients with liver cirrhosis : assessed by 3.0-T MRS
スポンサーリンク
概要
- 論文の詳細を見る
- 2004-09-01
著者
-
SUZUKI Kazuyuki
Iwate Medical University
-
SUZUKI KAZUYUKI
First Department of Internal Medicine, Iwate Medical University
-
Sawara Kei
Iwate Medical University
-
Kato Akinobu
First Department Of Internal Medicine Iwate Medical University
-
Kato Akinobu
Morioka Municipal Hospital
-
Yoshioka Yoshichika
Second Department Of Physiology Iwate Medical University School Of Medicine
-
SAWARA Kei
First Department of Internal Medicine, Iwate Medical University School of Medicine
-
Suzuki Kazuyuki
First Department Of Internal Medicine Iwate Medical University
関連論文
- Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan
- A male patient with severe acute hepatitis who was domestically infected with a genotype H hepatitis B virus in Iwate, Japan
- Primary Carcinoid Tumor of the Liver : A Case Report
- Ursodeoxycholic acid inhibits histamine release from rat peritoneal mast cells
- Changes in liver function parameters after percutaneous radiofrequency ablation therapy in patients with hepatocellular carcinoma
- Evaluation of newly developed combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma with portal venous invasion : preliminary results
- Seroprevalence of anti-HEV and epidemiological features in hog raising area and non hog raising area
- A case of acute hepatitis E associated with multidrug hypersensitivity and cytomegalovirus reactivation
- Interleukin-17 as a new marker of severity of acute hepatic injury
- Clinical epidemiology of fulminant hepatitis in Japan before the substantial introduction of liver transplantation : an analysis of 1309 cases in a 15-year national survey
- Proinflammatory cytokines up-regulate synthesis and secretion of urinary trypsin inhibitor in human hepatoma HepG2 cells
- Epidemiological and clinical study of sporadic acute hepatitis E caused by indigenous strains of hepatitis E virus in Japan compared with acute hepatitis A
- Contrast-Enhanced Ultrasonography Using Levovist : Usefulness of Diagnosis of Small Focal Nodular Hyperplasia Lesions
- Serum levels of soluble Fas ligand in patients with acute and fulminant hepatitis : relationship with soluble Fas, tumor necrosis factor α and TNF receptor-1
- Serum hyaluronate in patients with acute and fulminant hepatitis
- Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis
- Regional differences in cerebral glucose metabolism in cirrhotic patients with subclinical hepatic encephalopathy using positron emission tomography
- Serum soluble CD44 levels in patients with acute and fulminant hepatitis Relationship with serum hyaluronate levels
- Preliminary note Decreased brain concentrations of choline and acetylcholine in mice with thioacetamide-induced acute liver failure
- Pretreatment hepatitis C virus dynamics for predicting virological response to interferon-α2b monotherapy in patients with chronic hepatitis C virus infection
- Development of quantitative neuropsychological tests for diagnosis of subclinical hepatic encephalopathy in liver cirrhosis patients and establishment of diagnostic criteria-multicenter collaborative study in Japanese
- Nucleotide Substitutions of Hepatitis E Virus Genomes Associated with Fulminant Hepatitis and Disease Severity
- Quantitative Measurement of Thymidylate Synthase and Dihydropyrimidine Dehydrogenase mRNA Level in Gastric Cancer by Real-time RT-PCR
- Induction of Bcl-xL is a possible mechanism of anti-apoptotic effect by prostaglandin E2 EP4-receptor agonist in human hepatocellular carcinoma HepG2 cells
- Apoptotic hepatocellular carcinoma HepG2 cells accelerate blood coagulation
- Liver Fat Content Measured by Magnetic Resonance Spectroscopy at 3.0 Tesla Independently Correlates with Plasminogen Activator Inhibitor-1 and Body Mass Index in Type 2 Diabetic Subjects
- Prostaglandin E2 receptor EP4 agonist induces Bcl-xL and independently activates proliferation signals in mouse primary hepatocytes
- Marked improvement in the resolution of, and survival rates in, spontaneous bacterial peritonitis
- Branched-chain amino acid treatment in patients with liver cirrhosis
- How to select BCAA preparations
- Beneficial effect of Cyclosporin A on acute hepatic injury induced by galactosamine and lipopolysaccharide in rats
- Analysis of the genotype-determining region of hepatitis A viral RNA in relation to disease severities
- IMPROVEMENTS IN THE PATHOPHYSIOLOGY AND THE QOL OF LIVER CIRRHOSIS BY NUTRITIONAL TREATMENT WITH BRANCHED-CHAIN AMINO ACIDS
- Fasting plasma ghrelin levels reflect malnutrition state in patients with liver cirrhosis
- Serum leptin concentrations in liver cirrhosis : relationship to the severity of liver dysfunction and their characteristic diurnal profiles
- Analysis of SMAD4/DPC4 gene alterations in multiploid colorectal carcinomas
- Immunoreactivity of antimitochondrial autoantibodies in Japanese patients with primary biliary cirrhosis
- Diagnosis of sub-clinical hepatic encephalopathy by Neuropsychological Tests (NP-tests)
- Brain glutamine and glutamate levels in patients with liver cirrhosis : assessed by 3.0-T MRS
- NEW ENDOSCOPIC TECHNIQUE TO CLOSE LARGE MUCOSAL DEFECTS AFTER ENDOSCOPIC MUCOSAL RESECTION IN PATIENTS WITH GASTRIC MUCOSAL TUMORS
- ENDOSCOPIC CLOSURE OF MUCOSAL DEFECTS WITH METALLIC CLIPS AFTER ENDOSCOPIC MUCOSAL RESECTION IN PATIENTS WITH INTRAMURAL TUMORS OF THE STOMACH : A RETROSPECTIVE STUDY
- A novel prostaglandin E receptor subtype agonist, 0N0-4819, attenuates acute experimental liver injury in rats
- Clinical epidemiology of fulminant hepatitis in Japan
- Combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma
- Guidelines on nutritional management in Japanese patients with liver cirrhosis from the perspective of preventing hepatocellular carcinoma